The salt-resistant, antimicrobial properties of CAP18 and SMAP29 suggest potential for the treatment of bacterial infections in individuals with cystic fibrosis, who have high levels of sodium chloride in the sweat [103, 104]. This evidence concerns the gene CAMP and cystic fibrosis.